• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Chemotherapy in addition to local therapy may improve overall survival in patients aged 70 years or older with triple-negative breast cancer

byTeddy Guo
January 20, 2021
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click to read the study in The Lancet Oncology

RELATED REPORTS

Ivonescimab improves survival in advanced non-small cell lung cancer

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

Tags: adjuvant chemotherapyBreast Cancerneoadjuvant chemotherapyoncologytriple negative breast cancer
Previous Post

#VisualAbstract: Lower dose of ketorolac found to be non-inferior for pain management of renal colic

Next Post

Fractional doses of yellow fever vaccines are non-inferior to standard doses in seroconversion at 28 days post-vaccination 

RelatedReports

Lessons from real-world implementation of lung cancer screening
Chronic Disease

Ivonescimab improves survival in advanced non-small cell lung cancer

April 30, 2025
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Gastroenterology

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

April 16, 2025
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

April 13, 2025
One-year of Herceptin preferable to two-year regimen
Oncology

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

April 11, 2025
Next Post
Compliance-linked incentives increase infant immunizations rates in rural India

Fractional doses of yellow fever vaccines are non-inferior to standard doses in seroconversion at 28 days post-vaccination 

#VisualAbstract: Every-other-day dosing of oral rimegepant is effective for preventive treatment of migraines

#VisualAbstract: Retrospective study identifies common hospital complications associated with COVID-19

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Endothelial Activation and Stress Index as a predictor of mortality in patients with atrial fibrillation
  • No difference between pharmacologic treatments in age-related macular degeneration risk reduction
  • Vaccinations may be associated with small but temporary changes in menstrual cycle length
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.